B56γ expression was found to be downregulated in lung cancer, and concordantly, overexpression of B56γ has been shown to be tumor suppressive in multiple cancer models (lung, breast, and prostate cancer cell lines) (108, 119). Here, PPP2R5C is linked to lung carcinoma.